Market Tracker

01/16 1:05pm ET

Perrigo Company PLC (NYSE:PRGO)

77.80
Delayed Data
As of Jan 13
 -0.38 / -0.49%
Today’s Change
76.08
Today|||52-Week Range
152.36
-6.52%
Year-to-Date
Memo to Paul Price on Fastenal
Jan 13 / TheStreet.com - Paid Partner Content
Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different
Jan 11 / TheStreet.com - Paid Partner Content
Why Perrigo, Novadaq Technologies, and Ethan Allen Interiors Slumped Today
Jan 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close78.18
Today’s open78.40
Day’s range77.75 - 79.34
Volume1,527,759
Average volume (3 months)1,815,152
Market cap$11.2B
Dividend yield0.75%
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+36.36%
P/E ratio16.4
Price/Sales3.82
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.81+1.48%
SGENSeattle Genetics Inc+0.26+0.44%
TSROTESARO Inc+9.43+6.42%
RDYDr.Reddy's Laborator...+0.18+0.41%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts